Qiang Wu

机构：Macau University of Science and Technology, Weifang Medical University, Dalian Medical University, Nantong University, Tianjin Medical University General Hospital, Second Affiliated Hospital of Dalian Medical University, Second People's Hospital of NanTong, Weifang People's Hospital, Chinese Academy of Fishery Sciences · ORCID：0000-0003-2049-1639

发表论文 246 篇 · 总被引 11246 次 · h-index 45

代表论文

• An eyecare foundation model for clinical assistance: a randomized controlled trial (2025 · Nature Medicine · 被引 45)
• Comprehensive assessment of cellular senescence in intestinal immunity and biologic therapy response in ulcerative colitis (2024 · Scientific Reports · 被引 14)
• Inhibition of Wnt/β-catenin increases anti-tumor activity by synergizing with sorafenib in hepatocellular carcinoma (2025 · Cell Death and Disease · 被引 13)
• Role of Neutrophil Extracellular Traps in Hypertension and Their Impact on Target Organs (2024 · Journal of Clinical Hypertension · 被引 9)
• Fuzuloparib as maintenance therapy among patients with advanced ovarian cancer after a response to first-line platinum-based chemotherapy: Results from a randomized, placebo-controlled, phase III trial (2024 · Gynecologic Oncology · 被引 7)
• 149MO Irpagratinib (ABSK-011) plus atezolizumab in first-line (1L) and immune checkpoint inhibitors (ICIs) treated advanced hepatocellular carcinoma (HCC) with FGF19 overexpression (+): Updated results of the phase II ABSK-011-201 study (2025 · Annals of Oncology · 被引 6)